Search results
- 18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type / Balogova S., Talbot JN ... et al. . European Journal of Nuclear Medicine and Molecular Imaging . - Vol. 40, no. 6 (2013), s. 943-966 [Dokument nie je vo fonde knižnice]
article
- Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease / Talbot J. N., Balogová S. et al. . Journal of nuclear medicine . - Vol. 51, no. 11 (2010), s. 1699-1706 [Dokument nie je vo fonde knižnice]
article
- Diagnosis of bone metastasis: recent comparative studies of imaging modalities / Talbot JN, Paycha F., Balogova S. . The quarterly journal of nuclear medicine and molecular imaging . - Vol. 55, no. 4 (2011), s. 374-410 [Dokument nie je vo fonde knižnice]
article
- Characterisation and initial staging of prostate cancer: prospective determination of FCH PET/CT impact and comparison of its diagnostic performance vs. Contrastenhanced CT or MRI / Balogova S. ... [et al.] . Nukleární medicína : molekulární výzkum, diagnostika a terapie. - ISSN 1805-1146 . - Roč. 1, č. 3 (2012), s. 3 . Sborník vybraných abstrakt
- C 3127
article
- Localisation of recurrent prostate cancer: prospective determination of FCH PET/CCT imapct and comparison of its diagnostic performance vs. contrast-enhanced CT or MRI / Huchet V ... [et al.] . Nuklearmedizin . - 6 (2011), s. A 153 [Dokument nie je vo fonde knižnice]
article
- Significance of high prostate fluorodeoxyglucose (18F) uptake in a patient with no history of prostate cancer. Clinical cases, review and meta-analysis of literature / Kaliska L. ... [et al.] . Médecine nucléaire. - ISSN 0928-1258 . - Vol. 38, no 4 (2014), s. 266-274 [Dokument nie je vo fonde knižnice]
article